Acadia Pharmaceuticals Inc (ACAD)
EBITDA Margin
10.20%
TTM · Period ending:
ACAD EBITDA Margin
Latest reported10.20%period ending
Latest reported10.20%period ending
ACAD TTM EBITDA Margin (-278.16% → 10.20%)
TTM ebitda margin
High-resolution chart · PNG
ACAD ebitda margin history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Margin |
|---|---|
| 10.1979% | |
| 11.5871% | |
| 14.061% | |
| 12.761% | |
| 12.5092% | |
| 12.4524% | |
| 12.5142% | |
| 16.0346% | |
| 6.4234% | |
| 3.1407% | |
| -6.2612% | |
| -20.1342% | |
| -18.6447% | |
| -27.6563% | |
| -40.8747% | |
| -41.7176% | |
| -39.2821% | |
| -42.7328% | |
| -33.9816% | |
| -39.7294% | |
| -56.0822% | |
| -56.8871% | |
| -64.2107% | |
| -65.1661% | |
| -59.1916% | |
| -67.1194% | |
| -71.8951% | |
| -84.7453% | |
| -102.3549% | |
| -116.5331% | |
| -109.2187% | |
| -118.4549% | |
| -135.3934% | |
| -160.6267% | |
| -231.055% | |
| -319.3856% | |
| -483.9295% | |
| -947.3063% | |
| -1,563.597% | |
| -4,434.1441% | |
| -131,156.051% | |
| -284,686.8852% | |
| -268,795.082% | |
| -161,561.5385% | |
| -198,617.9104% | |
| -122,912.766% | |
| -77,519.1667% | |
| -69,686.3636% | |
| -18,661.4925% | |
| -6,593.6675% | |
| -3,337.7293% | |
| -2,210.3495% | |
| -517.8375% | |
| -425.277% | |
| -423.4155% | |
| -376.5982% | |
| -988.2035% | |
| -1,109.318% | |
| -1,091.7755% | |
| 32.6438% | |
| 33.5803% | |
| 37.9652% | |
| 37.2659% | |
| -257.4471% | |
| -304.5749% | |
| -425.8551% | |
| -693.3104% | |
| -1,015.4824% | |
| -2,037.1653% | |
| -5,439.6373% | |
| -4,171.4465% | |
| -2,460.5337% | |
| -1,606.4559% | |
| -1,042.5715% | |
| -814.0966% | |
| -737.1724% | |
| -666.4209% | |
| -682.6386% | |
| -595.6479% | |
| -515.6031% | |
| -433.4966% | |
| -350.9881% | |
| -317.4584% | |
| -327.051% | |
| -330.6056% | |
| -402.7275% | |
| -538.4011% | |
| -688.9442% | |
| -517.0463% | |
| -370.8648% | |
| -278.1627% |